Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
暂无分享，去创建一个
S. Parmar | R. Orlowski | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | R. Champlin | J. Shah | P. Kebriaei | B. Oran | N. Shah | A. Cornelison | S. M. Kazmi | M. Nusrat | Hilal Gunaydin